Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001062993-25-005900
Filing Date
2025-03-19
Accepted
2025-03-19 16:34:49
Documents
2
Period of Report
2025-03-17

Document Format Files

Seq Description Document Type Size
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.html 3  
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.xml 3 1616
2 POA exhibit24-1.txt EX-24.1 2563
  Complete submission text file 0001062993-25-005900.txt   5782
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Issuer) CIK: 0001267565 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O COLLEGIUM PHARMACEUTICAL, INC 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address
Dieter David (Reporting) CIK: 0002061438 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37372 | Film No.: 25753238